Patent · US Active

Biodegradable implant

US10478527B2 · kind B2 · utility

0Cited by
0References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 5, 2016
Grant dateNov 19, 2019
Priority date
Expiry dateSep 5, 2036

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61L2430/32
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

This invention relates to biodegradable implants comprising a hydrogel carrier matrix having dispersed therein a multitude of particles, wherein each of the multitude of particles and/or the hydrogel carrier matrix includes an active pharmaceutical ingredient (API) for the treatment of transected peripheral nerve injuries. Each of the multitude of particles and/or the hydrogel carrier matrix includes pristine polymer particles, preferably the pristine polymer particles may be polymethylmethacrylate polymers and derivatives thereof, preferably poly(methacrylic-co-methyl methacrylate) (PMMA). The spheroidal particles may each be formed from an outer shell including a chitosan (CHT) poly(methacrylic-co-methyl methacrylate) (PMMA) polyelectrolyte complex (CHT-PMMA-PEC) and an inner core including crosslinked chitosan having dispersed therein PMMA nanoparticles.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.